Farmacogenética, Genética del Cáncer, Polimorfismos Genéticos y Farmacoepidemiología
Universidade Do Porto
Oporto, PortugalPublicaciones en colaboración con investigadores/as de Universidade Do Porto (7)
2020
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
2017
-
Exercise Intervention in Pediatric Patients with Solid Tumors: The Physical Activity in Pediatric Cancer Trial
Medicine and Science in Sports and Exercise, Vol. 49, Núm. 2, pp. 223-230
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nature Genetics, Vol. 49, Núm. 5, pp. 680-691
-
Telomere length in elite athletes
International Journal of Sports Physiology and Performance, Vol. 12, Núm. 7, pp. 994-996
2014
-
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS Genetics, Vol. 10, Núm. 4
-
Hepatotoxicity related to agomelatine and other new antidepressants: A case/noncase approach with information from the portuguese, French, Spanish, and Italian pharmacovigilance systems
Journal of Clinical Psychopharmacology, Vol. 34, Núm. 3, pp. 327-330
2011
-
International distribution and age estimation of the Portuguese BRCA2 c.156-157insAlu founder mutation
Breast Cancer Research and Treatment, Vol. 127, Núm. 3, pp. 671-679